Aspen Investment Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Buy
+1,768
New +$233K 0.06% 182
2018
Q4
Sell
-2,625
Closed -$203K 135
2018
Q3
$203K Buy
+2,625
New +$198K 0.13% 142
2018
Q2
Sell
-2,750
Closed -$207K 150
2018
Q1
$207K Buy
+2,750
New +$219K 0.15% 135
2017
Q4
Sell
-2,750
Closed -$223K 143
2017
Q3
$223K Sell
2,750
-100
-4% -$7.65K 0.17% 124
2017
Q2
$202K Buy
+2,850
New +$190K 0.15% 126
2017
Q1
Sell
-3,050
Closed -$218K 131
2016
Q4
$218K Hold
3,050
0.16% 121
2016
Q3
$241K Hold
3,050
0.19% 111
2016
Q2
$254K Sell
3,050
-210
-6% -$18.6K 0.21% 105
2016
Q1
$299K Sell
3,260
-600
-16% -$54.1K 0.27% 88
2015
Q4
$391K Hold
3,860
0.39% 72
2015
Q3
$379K Sell
3,860
-1,115
-22% -$124K 0.37% 74
2015
Q2
$582K Buy
4,975
+110
+2% +$12K 0.49% 55
2015
Q1
$477K Sell
4,865
-50
-1% -$5.08K 0.38% 68
2014
Q4
$463K Sell
4,915
-250
-5% -$25.9K 0.39% 72
2014
Q3
$550K Sell
5,165
-7,190
-58% -$704K 0.46% 56
2014
Q2
$1.02M Buy
12,355
+250
+2% +$19.5K 0.63% 51
2014
Q1
$858K Hold
12,105
0.55% 59
2013
Q4
$909K Buy
12,105
+1,885
+18% +$131K 0.61% 59
2013
Q3
$643K Hold
10,220
0.46% 74
2013
Q2
$524K Buy
+10,220
New +$533K 0.36% 77

Other funds holding GILD

Aspen Investment Management's GILD Position: Q2 2026 in Review

Aspen Investment Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 1,768 shares worth $223K. The stake represents 0.06% of the portfolio and ranks #182 among its holdings. This is a return to the name: Aspen Investment Management previously reported a position in GILD as recently as Q3 2018.

Aspen Investment Management first reported a position in GILD in Q2 2013 and has held it in 20 quarters since. The position peaked at $1.02M in Q2 2014. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Aspen Investment Management held 1,768 shares of Gilead Sciences worth $223K as of Q2 2026.
  • Gilead Sciences was a new Aspen Investment Management position in Q2 2026.
  • Gilead Sciences made up 0.06% of Aspen Investment Management's portfolio in Q2 2026, its #182 holding.
  • Aspen Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 20 quarters since.
  • Aspen Investment Management's Gilead Sciences position peaked at $1.02M in Q2 2014.
  • 836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aspen Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.